(DNOV) FT Cboe Vest U.S. Equity - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome

DNOV: Options, ETF, Equity, Index

The FT Cboe Vest U.S. Equity Deep Buffer ETF - November (DNOV) is a defined outcome ETF designed to provide investors with exposure to the S&P 500 while incorporating downside protection. Under normal market conditions, the fund allocates substantially all its assets to FLEX Options, which are exchange-traded, customizable option contracts. These options are tied to the SPDR S&P 500 ETF Trust, allowing the fund to seek returns based on the S&P 500s performance while mitigating potential losses. The ETF is non-diversified, concentrating its investments in these specialized options to achieve its defined outcome strategy.

As of the latest data, DNOV has an average 20-day volume of 9,416 shares, indicating moderate trading activity. The funds last price was 43.32, with a 20-day SMA of 43.59 and a 50-day SMA of 43.36, suggesting a slight bullish trend in the short term. The 200-day SMA of 42.32 indicates longer-term stability. The ATR of 0.26 reflects low volatility, suggesting the funds price movements are relatively stable. With an AUM of $326.61 million, DNOV is a sizeable fund in its category, focusing on delivering specific risk-adjusted returns through its options-based strategy.

Based on the technical and fundamental data, here is a 3-month forecast: - Price Movement: The fund is expected to remain range-bound between 42.50 and 44.50, supported by its low ATR of 0.26 and stable SMAs. - Volume: Average daily volume may remain consistent at around 9,000-10,000 shares, indicating moderate investor interest. - Market Conditions: The funds performance will likely track the broader S&P 500 trends, with its FLEX Options structure providing downside buffer against potential declines. - AUM Growth: AUM may see incremental growth, driven by investor demand for defined outcome strategies in volatile markets.

Additional Sources for DNOV ETF

DNOV ETF Overview

Market Cap in USD 326m
Category Defined Outcome
TER 0.85%
IPO / Inception 2019-11-15

DNOV ETF Ratings

Growth 5y 74.1%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -4.55
Analysts -
Fair Price Momentum 41.03 USD
Fair Price DCF -

DNOV Dividends

No Dividends Paid

DNOV Growth Ratios

Growth Correlation 3m 1.1%
Growth Correlation 12m 94.5%
Growth Correlation 5y 82.5%
CAGR 5y 9.10%
CAGR/Max DD 5y 0.95
Sharpe Ratio 12m 1.03
Alpha -1.26
Beta 0.30
Volatility 11.13%
Current Volume 10k
Average Volume 20d 7.1k
What is the price of DNOV stocks?
As of March 13, 2025, the stock is trading at USD 41.85 with a total of 9,996 shares traded.
Over the past week, the price has changed by -2.49%, over one month by -4.15%, over three months by -3.64% and over the past year by +4.55%.
Is FT Cboe Vest U.S. Equity a good stock to buy?
Yes. Based on ValueRay Analyses, FT Cboe Vest U.S. Equity (BATS:DNOV) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 74.06 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DNOV as of March 2025 is 41.03. This means that DNOV is currently overvalued and has a potential downside of -1.96%.
Is DNOV a buy, sell or hold?
FT Cboe Vest U.S. Equity has no consensus analysts rating.
What are the forecast for DNOV stock price target?
According to ValueRays Forecast Model, DNOV FT Cboe Vest U.S. Equity will be worth about 44.7 in March 2026. The stock is currently trading at 41.85. This means that the stock has a potential upside of +6.86%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 44.7 6.9%